WinstonWınston
Back
Stock

LNA Santé S.A.

LNA.PA
48
Medical - Care Facilities · Healthcare
Also trades as: 0OR2.L GBP 0.24 (+0.43%)
Price
€23.80
+0.40 (+1.71%)
Market Cap
€245.0M
Exchange
Euronext Paris
Winston Score
48
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Oct 10, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Weak
7/30
Growth
Good
10/20
Cash Flow
Strong
8/10
Stability
Mixed
3/10
Valuation
Good
6/10
Ownership
Good
10/15
Dividends
Strong
4/5

48 of 100 counted points = Winston Score 48.

Track this stock — start free trial

Share count rising — dilution

+6.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 9.6M (2021) → 10.3M (2025)

§Winston Score History

The full picture

LNA Santé is a French healthcare company that runs nursing homes and care facilities for elderly people. It also operates clinics that help patients recover after surgery or serious illness. The main customers are elderly residents needing long-term care and patients referred by hospitals for rehabilitation. LNA Santé is one of the mid-sized private care operators in France.

The company makes money by charging daily fees for beds in its facilities, with payments coming from residents, their families, and the French public health insurance system. LNA Santé operates almost entirely in France, with a small number of facilities in Portugal. With roughly 25,000 beds across its network, its competitive position depends on its regional density and relationships with local health authorities. The key growth driver is France's aging population, which is expected to increase demand for elder care over the coming decades, though the business faces ongoing pressure from rising staff costs and tight government reimbursement rates.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.4% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+10.9% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

40.6%ownership

↓ Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

€107M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

LNA Santé S.A. is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
11.7%
Thin — 11.7% gross margin
Profit after running costs
Operating Margin
7.3%
Modest — 7.3% operating margin
Return on the money invested
ROCE
5.4%
Weak — 5.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+10.1%
Steady sales growth (+10.1% YoY)
Profit growth
EPS YoY
+28.0%
Earnings growing fast (+28.0% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
273%
Turns 273% of profit into real cash
Spare cash per sale
FCF Margin
6.2%
Modest free cash flow (6.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.82
Heavy debt load (2.82)
Covers its interest
Interest Cover
2.29x
Tight — interest eats into profit (2.3x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
9.6x
Attractive valuation — P/E 9.6

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
-1.2
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.25%
Moderate income — 3.25% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+85.0%
Dividend growing fast (85.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial